microRNA与肿瘤发生的关系及在临床诊治中应用
被引量:5
摘要
microRNA(miRNA)是一类内源性非编码小分子RNA,通过阻遏mRNA的翻译来调控基因的表达,大量研究证明其与肿瘤的发生密切相关。该文将重点论述调控肿瘤发生、发展的miRNA,详细阐述这些短片段RNA在肿瘤的分子诊断及临床个体性治疗中的应用。
出处
《临床与实验病理学杂志》
CAS
CSCD
北大核心
2013年第7期779-782,共4页
Chinese Journal of Clinical and Experimental Pathology
基金
江苏高校优势学科建设工程资助(012062003010)
参考文献29
-
1Filipowicz W. RNAi: the nuts and bolts of the RISC machine[ J]. Cell, 2005,122(1) :17 -20.
-
2Guo H, Ingolia N T, Weissman J S, et al. Mamnmlian microR- NAs predominantly act to decrease target mRNA levels [ J ]. Na- ture, 2010,46 (7308) : 835 - 40.
-
3Felekkis K, Touvana E, Stefanou C H, Deltas C. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease[ J]. Hippokratia, 2010,14(4) :236 -40.
-
4Fiorueci G, Chiantore M V, Mangino G, et al. Cancer regulator microRNA: potential relevance in diagnosis, prognosis and treat- ment of cancer[J]. Curr Med Chem, 2012,19(4) :461 -74.
-
5Nakamura T, Canaani E, Croce C M. Oncogenic Alll fusion pro- teins target Drosha-mediated microRNA processing [ J ]. Proe Natl Acad Sci USA, 2007,104 (26) : 10980 - 5.
-
6Blenkiron C, Miska E A. microRNAs in cancer: approaches, ae- tiology, diagnostics and therapy[ J]. Hum Mol Genet, 2007,16 (1) :R106 -13.
-
7Rosenfeld N, Aharonov R, Meiri E, et al. MicroRNAs accurately identify cancer tissue origin [ J ]. Nat Biotechnol, 2008,26 ( 4 ) : 462 - 9.
-
8Kroh E M, Parkin R K, Mitchell P S, et al. Analysis of circulat- ing microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) [ J ]. Methods, 2010,50 (4) :298 -301.
-
9Varadhachary G R, Spector Y, Abbruzzese J L, et al. Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary [ J ]. Clin Cancer Res, 2011,17(12) :4063 -70.
-
10Ferracin M, Pedriali M, Veronese A, et al. MicroRNA profiling for the identification of cancers with unknown primary tissue-of-ori- gin[ J]. J Pathol, 2011,225 ( 1 ) :43 - 53.
同被引文献40
-
1Zhou, Yuan,Ling, Xian-Long,Li, Shi-Wei,Li, Xin-Qiang,Yan, Bin.Establishment of a human hepatoma multidrug resistant cell line in vitro[J].World Journal of Gastroenterology,2010,16(18):2291-2297. 被引量:17
-
2WU W K, LAW P T, LEE C W, et al. MicroRNA in colorectal cancer: from benchtop to bedside[J]. Carci- nogenesis, 2011,32 : 247- 253.
-
3LINK A, BALAGUER F, SHEN Y, et al. Fecal Mi- croRNAs as novel biomarkers for colon cancer screen- ing[J]. Cancer Epidermiol Biomarkers Prev, 2010, 19: 1766-1774.
-
4WANG C J, ZHOU Z G, WANG L, et al. Clinicopatho- logical significance of microRNA-31 <143 and -145 ex- pression in colorectal cancer[J]. Dis Markers, 2009,26: 27-34.
-
5NG E K,TSANG W P, NG S S, et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal canc er[J]. Br J Cancer, 2009,101 : 699- 706.
-
6SLABY O, SVOBODA M, FABIAN P, et al. Altered expression of miR-21, miR-31,miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer[J]. Oncology, 2007,72 : 397-402.
-
7XU T, ZHU Y, XlONG Y, et al. MicroRNA-195 sup- presses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells[J]. Hepatology, 2009,50:113-121.
-
8Qi L, Bart J, Tan L P, et al. Expression of miR-21 and its targets ( PTEN, PDCIM, TM1 ) in flat epithelial atypia of the breast in re- lation to ductal carcinoma in situ and invasive carcinoma[ J 1. BMC Cancer, 2009,9 : 163.
-
9Wang S, Xue S, Dai Y, et al. Reduced expression of microRNA- 100 confers unfavorable prognosis in patients with bladder cancer [ J]. Diagn Pathol, 2012,7 : 159.
-
10Giangreco A A, Vaishnav A, Wagner D, et al. Tumor suppressor microRNAs, miR-100 and-125b, are regulated by 1, 25-di- hydroxyvitamin D in primary prostate ceils and in patient tissue[J]. Cancer Prev Res, 2013,6(5) :483 -94.
引证文献5
-
1张永锋,郭长军,谭永港,杨敏,陈嫚茵.溃疡性结肠炎相关性结肠癌差异表达的miRNA的筛选研究[J].中国中西医结合消化杂志,2014,22(2):65-68. 被引量:10
-
2张晖,陈思诺,王仰坤,朱武凌.荧光原位杂交法检测肝细胞癌组织中miR-100的表达[J].临床与实验病理学杂志,2015,31(2):184-186.
-
3潘霞,王智慧,雷小勇.microRNAs与ABC转运蛋白介导的肿瘤多药耐药研究进展[J].中华肿瘤防治杂志,2015,22(8):644-648. 被引量:7
-
4翟丽敏,杨硕,李文通.miRNA-199a-5p通过SP1调节ERK5抑制乳腺癌MDA-MB-231细胞侵袭的机制[J].临床与实验病理学杂志,2015,31(9):981-985. 被引量:10
-
5韩晓翠,李百隆,于立辉,卢颖,毛俊,王波,沈洁,毛利民,宋波.盐霉素通过下调miR-221抑制乳腺癌MCF-7细胞增殖的实验观察[J].临床与实验病理学杂志,2018,34(9):962-967. 被引量:3
二级引证文献30
-
1沈孝云,波拉提·马卡比力,吴孟华,李嘉骏,苏超粤,张建业.鸦胆子素D调控肺癌干细胞干性分子的研究[J].中药材,2019,42(5):1160-1163. 被引量:2
-
2代春燕,郑雪冰,孔欣,袁媛,韩捷.韩捷教授运用中医四联疗法分期治疗溃疡性结肠炎经验探析[J].四川中医,2023,41(4):4-9. 被引量:2
-
3刘雪嘉,肖区龙,伍希,金敏,谭珊.Pim1蛋白在乳腺不同病变组织中的表达差异及临床特征[J].长沙医学院学报,2020(1):34-38.
-
4周艳,邢祖忠.溃疡性结肠炎患者RAGE表达及血清sRAGE水平的临床研究[J].中国临床研究,2015,28(7):848-850. 被引量:1
-
5邓文珺,马颖才,马丽莉.美沙拉嗪联合丹参注射液治疗溃疡性结肠炎的疗效及对患者炎性因子与凝血指标的影响[J].世界华人消化杂志,2016,24(3):462-466. 被引量:20
-
6水楠楠,郑红斌.健脾固肠排毒法治疗溃疡性结肠炎浅探[J].浙江中医杂志,2016,51(8):611-612. 被引量:1
-
7王建澍,宋建民,夏亚一.ERK5信号通路与恶性肿瘤研究进展[J].甘肃医药,2017,36(3):176-179. 被引量:2
-
8孙志广,秦晓静,张永亮,丁辉,刘子泉,宋月英,王成艳,王雪,李灵芝,吕琪.乳腺癌多药耐药DEDD作用及机制研究[J].中华肿瘤防治杂志,2017,24(16):1125-1129. 被引量:1
-
9申力,赵立志,申志诚.miR-26调控BID蛋白对结肠癌细胞增殖和侵袭的影响[J].解放军预防医学杂志,2017,35(10):1184-1188.
-
10曾小芳,熊艳杰,乌日娜,傅彩虹,张春香,冉淑玲,赵俊暕.抑制miRNA-301a表达对卵巢癌中SKOV3细胞增殖、迁移及侵袭的影响[J].临床与实验病理学杂志,2018,34(1):92-94. 被引量:12
-
1谭永刚,杨向红.miRNA和胰腺肿瘤[J].现代肿瘤医学,2012,20(4):847-850.
-
2叶湛,王敏,王发圣,林金銮,林建华,李祥.微小RNA-19b对骨肉瘤细胞增殖与凋亡的影响[J].中华实验外科杂志,2015,32(11):2901-2901.
-
3姜淑青,张钢,乔珊珊,李尊爱,王雪艳.小鼠肺腺癌细胞药敏试验中药物代谢酶的作用[J].卫生毒理学杂志,2002,16(3):176-177.
-
4陈芳,谢丽,禹立霞,刘宝瑞.肝胆胰恶性肿瘤患者游离DNA的含量及完整性的研究[J].实用临床医药杂志,2014,18(24):46-49.
-
5傅剑军,杨艺.胃癌发生新机制:小分子RNA[J].国际消化病杂志,2010,30(5):276-278.
-
6杨子江,张婷,高恒.MicroRNAs调节垂体腺瘤细胞周期的研究进展[J].临床神经外科杂志,2016,13(6):478-480. 被引量:2
-
7曹前.反义核苷酸抑制端粒酶活性与肿瘤的治疗[J].重庆医学,2001,30(5):458-460. 被引量:1
-
8李红燕,谢丽,禹立霞,刘宝瑞.血浆DNA含量及完整性在早期胃癌诊断中的价值[J].现代肿瘤医学,2015,23(10):1386-1389. 被引量:5
-
9张振,王凯,曹振龙,邵志强,郭丰富.小分子RNA干扰Notch1基因对肾癌Caki-1细胞增殖的影响[J].现代肿瘤医学,2014,22(2):292-295. 被引量:1
-
10林祥华,陈志哲,杨婷,吕联煌.bcl-2部分编码区的反义RNA促进烷化溶血磷脂诱导的白血病细胞凋亡[J].中华内科杂志,2002,41(1):48-49.